Articles and Materials For In Vitro Fertilization - ANVISA Registration 10318390011
Access comprehensive regulatory information for Articles and Materials For In Vitro Fertilization in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 10318390011 and manufactured by FUJIFILM IRVINE SCIENTIFIC, INC. The registration is held by Spectrun Bio Engenharia Médica Hospitalar Ltda. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including VITROLIFE SWEDEN AB, ALLWIN MEDICAL DEVICES, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10318390011
253510132650109
54446810000103
Company Information
Dates and Status
Dec 27, 2001
VIGENTE
09/18/2025 19:00:01
VITROLIFE SWEDEN AB• Sweden
ALLWIN MEDICAL DEVICES, INC• United States of America
LifeGlobal Group LLC• United States of America
OVERTURE LIFE, INC.• United States of America
COOPERSURGICAL, INC.• United States of America
Artigos e Materiais Para Fertilizacao In Vitro
Conjunto para Aspiração Folicular - Lúmen Único
VITROLIFE SWEDEN AB
83085839005
Aug 18, 2025
Artigos e Materiais Para Fertilizacao In Vitro
Conjunto de Aspiração Folicular - Lúmen Único, Luer com Tubo
VITROLIFE SWEDEN AB
83085839006
Aug 18, 2025
Artigos e Materiais Para Fertilizacao In Vitro
Conjunto de Aspiração Folicular - Lúmen Único com Luer
VITROLIFE SWEDEN AB
83085839007
Aug 18, 2025
Artigos e Materiais Para Fertilizacao In Vitro
Conjunto para Aspiração Folicular - Lúmen Duplo
VITROLIFE SWEDEN AB
83085839008
Aug 18, 2025
Artigos e Materiais Para Fertilizacao In Vitro
Ovoil Heavy™
VITROLIFE SWEDEN AB
83085839003
Jul 21, 2025

